Sleep apnea was associated with macular degeneration, with mixed subgroup findings
An observational review found higher overall odds of age-related macular degeneration among adults with sleep apnea, but several subgroup analyses were inconclusive.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Adults with obstructive sleep apnea had higher overall odds of age-related macular degeneration in the adjusted pooled analysis. Some subgroup and disease-stage analyses were not statistically significant. Because the included studies were observational, the findings cannot establish that sleep apnea causes eye disease or that treating apnea would prevent it.
This abstract-based summary reflects varying diagnostic definitions, substantial study variation in several analyses, and certainty ranging from moderate to very low. Observational data limit causal interpretation.
What researchers found
Adjusted odds ratio for age-related macular degeneration
For adults with versus without obstructive sleep apnea, odds were 1.44 times as high. Follow-up durations were unreported; evidence certainty was moderate. This is not an absolute risk estimate.
What the estimate captures
The adjusted odds ratio compares the odds of macular degeneration between groups after accounting for other factors. It describes a relative association; the abstract does not give an individual's absolute chance of developing the condition.
Why the mixed results matter
Results depended on how studies handled confounding and which disease stages they assessed. Nonsignificant subgroup findings do not prove an absence of association, but they qualify the overall pattern reported by the review.
The original publication
Obstructive sleep apnea and risk of age-related macular degeneration: A systematic review and meta-analysis.
Yaldo L, Ngo A, Yaldo M et al.
Am J Ophthalmol · 2026
- PubMed ID
- 41692178
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.